Who deserves equity in a university spin-off, and how much? These questions create some of the most contentious negotiations in knowledge transfer, and the answers can make or break a startup's future fundraising potential.
This panel tackles the practical challenges knowledge transfer offices face daily: What’s the effect of adding royalties and milestone payments on top of equity stakes? Should faculty who won't join as founders still receive equity? How much should universities take? We'll start with cap table fundamentals (how shares are allocated and how dilution works), then dive into real-world scenarios where theory meets messy reality.
Topics include:
The panel brings diverse experience from Cambridge, USC, venture capital, venture studios, and pharmaceutical licensing. Participants are encouraged to share their own challenges and lessons learned in structuring these deals.
Panelists: Declan Weldon (Cambridge Enterprise), Matt Wichrowski (VC and author), Rubén Darío Flores Saaib (Ligand Pharmaceuticals, formerly USC and General Inception), and Martin Raditsch (CARMA FUND Management and Innovectis GmbH). D'vorah Graeser, founder of RocketSmart AI, will moderate.
This webinar is organised by the Spin-off SIG. Join the Spin-off SIG to stay tuned.
Join our newsletter and get the latest news